165 related articles for article (PubMed ID: 34023743)
1. Evaluation of oral potentially malignant disorders with autoflorescence, reflectance spectroscopy and vital staining and their correlation with histopathology - Hospital based prospective study.
Sharma D; Rimal J; Kumar Maharjan I; Shrestha A; Shrestha A; Regmee P
Oral Oncol; 2021 Jul; 118():105312. PubMed ID: 34023743
[TBL] [Abstract][Full Text] [Related]
2. Clinical Evaluation of the Optical Filter for Autofluorescence Glasses for Oral Cancer Curing Light Exposed (GOCCLES
Lajolo C; Tranfa M; Patini R; Fiorino A; Musarra T; Boniello R; Moro A
Int J Environ Res Public Health; 2022 May; 19(9):. PubMed ID: 35564975
[TBL] [Abstract][Full Text] [Related]
3. Comparing the efficacy of chemiluminescence with lugol's iodine versus toluidine blue in the diagnosis of dysplasia in tobacco associated oral lesions - A diagnostic study.
Swathi KV; Maragathavalli G; Uma Maheswari TN
Indian J Dent Res; 2021; 32(4):459-466. PubMed ID: 35645072
[TBL] [Abstract][Full Text] [Related]
4. Assessment of oral mucosal lesions with autofluorescence imaging and reflectance spectroscopy.
Lalla Y; Matias MA; Farah CS
J Am Dent Assoc; 2016 Aug; 147(8):650-60. PubMed ID: 27117325
[TBL] [Abstract][Full Text] [Related]
5. Toluidine blue aids in detection of dysplasia and carcinoma in suspicious oral lesions.
Chainani-Wu N; Madden E; Cox D; Sroussi H; Epstein J; Silverman S
Oral Dis; 2015 Oct; 21(7):879-85. PubMed ID: 26173924
[TBL] [Abstract][Full Text] [Related]
6. Acetic acid versus toluidine blue as screening tools for oral potentially malignant disorders.
Winton Kalluvelil SR; Narayanan VS
Indian J Cancer; 2023; 60(3):427-431. PubMed ID: 36861696
[TBL] [Abstract][Full Text] [Related]
7. Autofluorescence imaging to identify oral malignant or premalignant lesions: Systematic review and meta-analysis.
Kim DH; Kim SW; Hwang SH
Head Neck; 2020 Dec; 42(12):3735-3743. PubMed ID: 32866310
[TBL] [Abstract][Full Text] [Related]
8. A study to evaluate the efficacy of toluidine blue and cytology in detecting oral cancer and dysplastic lesions.
Rahman F; Tippu SR; Khandelwal S; Girish KL; Manjunath BC; Bhargava A
Quintessence Int; 2012 Jan; 43(1):51-9. PubMed ID: 22259809
[TBL] [Abstract][Full Text] [Related]
9. Utility of toluidine blue as a diagnostic adjunct in the detection of potentially malignant disorders of the oral cavity--a clinical and histological assessment.
Awan Kh; Yang Y; Morgan P; Warnakulasuriya S
Oral Dis; 2012 Nov; 18(8):728-33. PubMed ID: 22524200
[TBL] [Abstract][Full Text] [Related]
10. The use of light-based (optical) detection systems as adjuncts in the detection of oral cancer and oral potentially malignant disorders: a systematic review.
Rashid A; Warnakulasuriya S
J Oral Pathol Med; 2015 May; 44(5):307-28. PubMed ID: 25183259
[TBL] [Abstract][Full Text] [Related]
11. Assessing the accuracy of autofluorescence, chemiluminescence and toluidine blue as diagnostic tools for oral potentially malignant disorders--a clinicopathological evaluation.
Awan KH; Morgan PR; Warnakulasuriya S
Clin Oral Investig; 2015 Dec; 19(9):2267-72. PubMed ID: 25804887
[TBL] [Abstract][Full Text] [Related]
12. Toluidine blue staining in the detection of oral precancerous and malignant lesions.
Silverman S; Migliorati C; Barbosa J
Oral Surg Oral Med Oral Pathol; 1984 Apr; 57(4):379-82. PubMed ID: 6200814
[TBL] [Abstract][Full Text] [Related]
13. Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas.
Onofre MA; Sposto MR; Navarro CM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):535-40. PubMed ID: 11346731
[TBL] [Abstract][Full Text] [Related]
14. Utility of toluidine blue staining and brush biopsy in precancerous and cancerous oral lesions.
Gupta A; Singh M; Ibrahim R; Mehrotra R
Acta Cytol; 2007; 51(5):788-94. PubMed ID: 17910350
[TBL] [Abstract][Full Text] [Related]
15. Comparison of chemiluminescence and toluidine blue in the diagnosis of dysplasia in leukoplakia: a cross-sectional study.
Chaudhry A; Manjunath M; Ashwatappa D; Krishna S; Krishna AG
J Investig Clin Dent; 2016 May; 7(2):132-40. PubMed ID: 25532724
[TBL] [Abstract][Full Text] [Related]
16. Value of the ViziLite Plus System as a diagnostic aid in the early detection of oral cancer/premalignant epithelial lesions.
Mojsa I; Kaczmarzyk T; Zaleska M; Stypulkowska J; Zapala-Pospiech A; Sadecki D
J Craniofac Surg; 2012 Mar; 23(2):e162-4. PubMed ID: 22446458
[TBL] [Abstract][Full Text] [Related]
17. Inter-and intra-observer agreement on the judgment of toluidine blue staining for screening of oral potentially malignant disorders and oral cancer.
Li YN; Lu R; Zhang J; Zhou G
Clin Oral Investig; 2019 Apr; 23(4):1709-1714. PubMed ID: 30155573
[TBL] [Abstract][Full Text] [Related]
18. Reliability of toluidine blue vital staining in detection of potentially malignant oral lesions--time to reconsider.
Upadhyay J; Rao NN; Upadhyay RB; Agarwal P
Asian Pac J Cancer Prev; 2011; 12(7):1757-60. PubMed ID: 22126560
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic efficiency of toluidine blue with Lugol's iodine in oral premalignant and malignant lesions.
Nagaraju K; Prasad S; Ashok L
Indian J Dent Res; 2010; 21(2):218-23. PubMed ID: 20657091
[TBL] [Abstract][Full Text] [Related]
20. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue.
Epstein JB; Silverman S; Epstein JD; Lonky SA; Bride MA
Oral Oncol; 2008 Jun; 44(6):538-44. PubMed ID: 17996486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
